Back

STANLEy score: a new predictive model of 3-year major adverse cardiac events following "Full Metal Jacket" using new-generation drug-eluting stents

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification in chronic coronary syndromes Revascularisation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Barbara Lacerda Teixeira

Hospital de Santa Marta, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Pre-test probability for coronary artery disease in patients with chest pain based on machine learning techniques
Miss J. Cha (KR)
Abstract Slides Video
Presentation thumbnail
Performance of ensemble of UNets for epicardial adipose tissue quantification: a multi-center APOLLO study
Professor L. Zhong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Does the pre-procedural pathophysiological pattern impact post-procedural hemodynamic outcomes and vessel prognosis in multivessel coronary artery disease?
Doctor S. KAGEYAMA (Shizuoka, JP)
Abstract Slides Video
Presentation thumbnail
Does ischaemia testing predict worse adverse outcomes in ANOCA patients?
Ms S. La (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Introducing the original web score calculator GARDENIA risk score for severe coronary artery (re)stenosis
Doctor D. Sarenac (Belgrade, RS)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in chronic coronary syndromes

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Comparison of machine learning and traditional methods for prediction of adverse clinical events after percutaneous coronary intervention
thumbnail
Congress Presentation
Examining prognostic scores for short-term major adverse cardiovascular events prediction following primary PCI: a comparative analysis
thumbnail
Congress Presentation
Development and validation of a long-term clinical prediction model for MACE associated with non-culprit lesions after percutaneous coronary intervention in patients with AMI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources